安諾其(300067.SZ):子公司申報的“山東省分散染料及助劑工程實驗室”被認定為山東省工程實驗室
格隆匯 7 月 6日丨安諾其(300067.SZ)公佈,根據《山東省發展和改革委員會關於公佈2020年認定山東省工程實驗室(工程研究中心)名單的通知》(魯發改高技[2020]809號),經評審論證,公司全資子公司東營安諾其紡織材料有限公司申報的“山東省分散染料及助劑工程實驗室”被認定為山東省工程實驗室。
該工程實驗室的認定,是對公司在中高端分散染料及其助劑領域自主研發水平、創新能力、技術人才等方面的充分肯定。公司將進一步加強在中高端分散染料及其助劑領域的新產品研發、應用創新以及研究成果向工程技術轉化的能力,引領企業高質量發展,為染料產業發展與應用做出積極貢獻。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.